Results 361 to 370 of about 199,652 (389)

Progress in research into systemic sclerosis

The Lancet, 2004
openaire   +3 more sources

Thinking outside the box: non-canonical targets in multiple sclerosis

Nature Reviews Drug Discovery, 2022
Orhan Aktas, Tobias Ruck, Michael Roden
exaly  

Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study

Lung, 2013
S. Panopoulos, V. Bournia, G. Trakada, I. Giavri, C. Kostopoulos, P. Sfikakis   +5 more
semanticscholar   +1 more source

Trends in peptide drug discovery

Nature Reviews Drug Discovery, 2021
David J Adams, Glenn F King, Markus Muttenthaler   +2 more
exaly  

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

Nature Reviews Drug Discovery, 2019
Jason R Plemel, Simon Faissner, V Wee Yong   +2 more
exaly  

Early integration of palliative care services with standard oncology care for patients with advanced cancer

Ca-A Cancer Journal for Clinicians, 2013
Joseph A Greer
exaly  

Cyclosporin A in progressive system sclerosis

Acta Paediatrica, 1995
CONSTANTOPOULOS, A, DRACOU, C, TSOUMAKAS, C   +2 more
openaire   +2 more sources

Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis

British Journal of Dermatology, 2013
Y. Yamaguchi, J. Ono, M. Masuoka, S. Ohta, K. Izuhara, Z. Ikezawa, M. Aihara, Kazuo Takahashi   +7 more
semanticscholar   +1 more source

Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications

Ca-A Cancer Journal for Clinicians, 2014
William W Tseng
exaly  

The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label study

Annals of the Rheumatic Diseases, 2010
Mike O. Becker, Claudia Brückner, Hans Scherer, N. Wassermann, J. Humrich, L. Hanitsch, Udo Schneider, A. Kawald, K. Hanke, G. Burmester, G. Riemekasten   +10 more
semanticscholar   +1 more source